Hubert Schoemaker
Encyclopedia
Hubert J. P. Schoemaker was a Dutch-American
chemist
and biotechnological
pioneer. Schoemaker was a co-founder and the president of the Bio-tech company Centocor
. He helped develop Remicade, a drug to treat auto-immune disorders like Crohn's disease
and rheumatoid arthritis
. After selling Centocor to Johnson and Johnson for $5.2 billion in 1999, Schoemaker went on to form Neuronyx, Inc., a biotech company focused on developing cellular therapies. As of 2007, Neuronyx is in clinical trials testing adult bone marrow-derived cells in heart attack patients.
United States
The United States of America is a federal constitutional republic comprising fifty states and a federal district...
chemist
Chemist
A chemist is a scientist trained in the study of chemistry. Chemists study the composition of matter and its properties such as density and acidity. Chemists carefully describe the properties they study in terms of quantities, with detail on the level of molecules and their component atoms...
and biotechnological
Biotechnology
Biotechnology is a field of applied biology that involves the use of living organisms and bioprocesses in engineering, technology, medicine and other fields requiring bioproducts. Biotechnology also utilizes these products for manufacturing purpose...
pioneer. Schoemaker was a co-founder and the president of the Bio-tech company Centocor
Centocor
Janssen Biotech, Inc., formerly Centocor Biotech, Inc., is a biotechnology company that was founded in Philadelphia in 1979 with an initial goal of developing new diagnostic assays using monoclonal antibody technology....
. He helped develop Remicade, a drug to treat auto-immune disorders like Crohn's disease
Crohn's disease
Crohn's disease, also known as regional enteritis, is a type of inflammatory bowel disease that may affect any part of the gastrointestinal tract from mouth to anus, causing a wide variety of symptoms...
and rheumatoid arthritis
Rheumatoid arthritis
Rheumatoid arthritis is a chronic, systemic inflammatory disorder that may affect many tissues and organs, but principally attacks synovial joints. The process produces an inflammatory response of the synovium secondary to hyperplasia of synovial cells, excess synovial fluid, and the development...
. After selling Centocor to Johnson and Johnson for $5.2 billion in 1999, Schoemaker went on to form Neuronyx, Inc., a biotech company focused on developing cellular therapies. As of 2007, Neuronyx is in clinical trials testing adult bone marrow-derived cells in heart attack patients.